Announcements

Job offersmore »



Tweeting Growers

Top 5 - yesterday

  • No news has been published yesterday.

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




CAN (QC): Planning underway for new Quebec cannabis project

MYM Nutraceuticals announces that GGS Structures and CannaCanada, subsidiary of MYM, are working together on the planning and design of the 1.5 million sq. ft. Weedon Cannabis Greenhouse Production Project.

Gerry Harrison of GGS Structures commented, "We are thrilled to be working with MYM Nutraceuticals on their project located at Weedon, Quebec. Planning is underway for the first phase of a greenhouse medical cannabis cultivation facility of approximately 100,000 sf. The completed state of the art growing facility will consist of 15 greenhouses that will total 1,500,000 sq. sf."

Weedon Health Canada commercial cannabis production license application has been submitted. MYM's consultants Factotum Consultants, who have successfully obtained Licensed Producer licenses for other clients, are managing the ACMPR application process and have submitted the Weedon application to Health Canada on June 28, 2017.

Weedon quality assurance position filled
David O'Halloran, BSc. has joined the MYM/CanaCanada team as the Quality Assurance Person for the Weedon Project. David O'Halloran brings sixteen years of Quality Assurance and Regulatory Affairs experience to the team. Having graduated from the Cork Institute of Technology in Ireland with a Bachelor of Science in Pharmaceutical Chemistry, David spent five years working in the laboratories of Novartis in the south Coast of Ireland. In 2006, he immigrated to Canada where he began working for PharmAthene Canada Inc., the Canadian division of an American biotech company contracted by the US Department of Defense to develop countermeasures for chemical and biological warfare. Following that he spent two years as Quality Assurance and Regulatory Affairs Director with Vivier Pharma.

David has since been consulting for companies to obtain their licenses from Health Canada, first under the Marihuana for Medical Purposes Regulations (MMPR), and later, the Access to Cannabis for Medical Purposes Regulations (AMPR), submitting applications on behalf of the companies, setting up quality management systems and helping in the design of production facilities to ensure optimal production efficiency and regulatory compliance.

For more information:
MYM Nutraceuticals
1-855-696-2261
info@mymarijuana.ca
www.mymarijuana.ca


GGS Structures
ggs-greenhouse.com

Publication date: 6/30/2017

 


 

Other news in this sector:

11/17/2017 CAN (BC): Should Delta get a share of lucrative pot bucks?
11/16/2017 Vancouver firm eyes Uruguayan MMJ market
11/16/2017 MedReleaf Australia receives cultivation license
11/16/2017 Jamaica: MMJ companies form alliance
11/16/2017 IBM wants British Columbia to track legal pot with blockchain tech
11/15/2017 Greece hopes to boost economy with MMJ
11/15/2017 Aurora Cannabis plans to take over CanniMed
11/15/2017 US (CA): Cannabis growers could face taxes on destroyed crops
11/14/2017 US (NV): Grower hits record-breaking THC & terpene profiles
11/14/2017 US (CA): Coachella City approves cannabis greenhouse facility
11/13/2017 Canada: Supreme commences production in new flowering rooms
11/10/2017 CAN (ON): Beleave to expand with 80,000 sq. ft. in Hamilton
11/10/2017 Macedonian MMJ grower invests in LED
11/9/2017 Academic research into HPS vs. LED for cannabis cultivation
11/8/2017 Maximizing cannabis yields using controlled environment technology
11/8/2017 US (OH): Provisional licenses for Level II marijuana cultivators
11/8/2017 US (ME): Marijuana grower develops mechanical farmhand
11/8/2017 CAN (QC): Aurora receives cultivation license for Pointe-Claire site
11/7/2017 Biotech company and UC Davis to unravel cannabis genomics
11/7/2017 "Strong increase in cannabis production with bubble oxygenation"